VeriStar Capital Management LP Increases Position in Humana Inc. (NYSE:HUM)

VeriStar Capital Management LP increased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 16.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,239 shares of the insurance provider's stock after purchasing an additional 3,539 shares during the period. Humana makes up about 10.7% of VeriStar Capital Management LP's portfolio, making the stock its 3rd biggest holding. VeriStar Capital Management LP's holdings in Humana were worth $6,403,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in HUM. Transcend Capital Advisors LLC raised its position in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after buying an additional 2,914 shares in the last quarter. FNY Investment Advisers LLC raised its holdings in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after acquiring an additional 26,856 shares in the last quarter. Retirement Systems of Alabama lifted its position in shares of Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Humana by 7.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after purchasing an additional 65,735 shares in the last quarter. Finally, Secure Asset Management LLC bought a new position in shares of Humana in the fourth quarter worth $244,000. 92.38% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Guggenheim assumed coverage on shares of Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective for the company. StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a report on Monday, April 7th. Piper Sandler lifted their price objective on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. Royal Bank of Canada restated an "outperform" rating and set a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Finally, Truist Financial lifted their price target on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Seventeen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $284.90.

Humana Trading Down 1.6 %

NYSE HUM traded down $4.29 on Tuesday, reaching $258.91. The company had a trading volume of 2,471,973 shares, compared to its average volume of 1,750,020. The firm has a market cap of $31.25 billion, a price-to-earnings ratio of 26.02, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The business has a 50 day moving average of $266.31 and a two-hundred day moving average of $270.84. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.37%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.